Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - HEALTH DISCOVERY CORP | t82579_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 16, 2015
Health Discovery Corporation
(Exact name of registrant as specified in charter)
Georgia | 333-62216 | 74-3002154 |
(State of incorporation) | (Commission File Number) |
(IRS Employer Identification No.) |
4243 Dunwoody Club Drive, Suite 202, Atlanta GA 30350
(Address of principal executive offices / Zip Code)
(678) 336-5300
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act. | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act. | |
o | Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act. | |
o | Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act. |
ITEM 8.01 | Other Events |
In January 2007, SVM Capital, LLC (“SVM Capital”) was formed as a joint venture between Health Discovery Corporation (“HDC”) and Atlantic Alpha Strategies, LLC (“Atlantic Alpha”) to explore and exploit the potential applicability of HDC’s SVM technology to quantitative investment management techniques. On June 16, 2015, SVM Capital joined Manifold Partners, LLC (“ Manifold Partners”) as a partner.
On June 16, 2015, Manifold Partners issued a press release announcing SVM Capital joining Manifold Partners. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
ITEM 9.01 | Financial Statements and Exhibits |
(a) | Not applicable | |
(b) | Not applicable | |
(c) | Not applicable | |
(d) | Exhibits | |
99.1 Press Release Manifold Partners, LLC dated June 16, 2015. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HEALTH DISCOVERY CORPORATION | |||
|
|
||
Dated: June 17, 2015 | By: | /s/ Kevin Kowbel | |
Chairman & Interim Chief Executive Officer | |||